Pharma Equity Group A/S Cl A Cash Flow Quality Index
Pharma Equity Group A/S Cl A cash flow quality index. Pharma Equity Group A/S Cl A (PEG) has a Cash Flow Quality Index of 0.36x as of December 2022. Operating cash flow of Dkr4.24 Million is below net income of Dkr11.63 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore PEG debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Pharma Equity Group A/S Cl A (2017–2022)
Cash flow quality index of Pharma Equity Group A/S Cl A from 2017 to 2022. Historical Cash Flow Quality Index for Pharma Equity Group A/S Cl A across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. See PEG net asset quality score to measure how much of total assets are equity-financed.
Pharma Equity Group A/S Cl A Cash Flow Quality Index by Year (2017–2022)
Pharma Equity Group A/S Cl A cash flow quality index by year from 2017 to 2022. Year-by-year earnings quality comparison for Pharma Equity Group A/S Cl A. For the full cash flow conversion analysis, see Pharma Equity Group A/S Cl A (PEG) cash conversion ratio.
| Year | Quality Index | Operating CF (DKK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -0.83x | Dkr-2.87 Million | Dkr3.48 Million | ▼ -113.2% |
| 2021 | -0.39x | Dkr-2.09 Million | Dkr5.39 Million | ▲ +98.6% |
| 2017 | -27.80x | Dkr-4.92 Million | Dkr177.00K | — |